White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.
Level 5 - mechanism / opinion, no new human data
Consensus statement and methodological framework with no empirical patient data
PubMed 26830300 · doi:10.1016/j.vaccine.2015.10.082
What was done
The Centers for Disease Control and Prevention (CDC) commissioned a White Paper developed with subject-matter experts to assess how the Vaccine Safety Datalink (VSD) could be used to evaluate the safety of the recommended childhood immunization schedule versus alternative or delayed schedules. The authors outlined a four-stage approach to categorize undervaccinated exposure groups, identified priority health outcomes, and evaluated study designs and statistical techniques for observational assessment.
What was found
The abstract reports no numerical findings or health outcome data. It reports that evaluating the childhood immunization schedule within the VSD is feasible, but emphasizes that studies will be complex and require careful control for confounding and bias, alongside consideration of biological plausibility, epidemiological evidence, and public concerns.
Why it matters
This white paper establishes a standardized methodological roadmap for designing observational studies to evaluate the safety of the overall childhood vaccination schedule using large electronic health databases.
Limits
The abstract presents no empirical patient data, comparative risk estimates, or clinical trial findings. Any future studies applying this framework will be observational and inherently subject to selection bias and unmeasured confounding between fully vaccinated and undervaccinated cohorts.
Cited by
- supports There is no scientific research demonstrating that an alternative or slower spaced-out vaccine schedule reduces the risk of adverse events or reactions compared to the standard schedule.